Team reports progress in developing specific immunotherapy for type 1 diabetes
credit: autoimmune journal (2024). DOI: 10.1016/j.jaut.2024.103196 Researchers at Germany’s Institut Trias i Puyol (IGTP) and Ahead Therapeutics SL have been researching liposomal nanoparticle-based therapies to combat autoimmunity in type 1…